C

COMPASS Pathways Plc
D

CMPS

11.160
USD
-0.44
(-3.79%)
قبل الجلسة·11.590USD+0.430(+3.85%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
11,709
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
1,545,401,334
نظرة عامة
أصول ذات صلة
F
FAF
D
First American Financial Corp
64.950
-0.065(-0.10%)
64.530-0.420(-0.65%)
MAPSUSD
MAPSUSDMAPS / United States Dollar
0.43330
0.00150(0.35%)
NUMI
NUMI
D
Nuveen Municipal Income ETF
24.200
0.315(1.32%)
T
TRIP
D
TripAdvisor
9.46500
-0.21000(-2.17%)
المزيد

العنوان: COMPASS Pathways Plc

القطاع: الرعاية الصحية
الصناعة: Medical Care Facilities
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.